[lemma=fast] □
[lemma=fast] □ □
[lemma=fast] (□ | □)
Phenoxodiol ( Marshall Edwards Inc ., New South Wales , Australia ) also has been granted fast track status for the treatment of recurrent ovarian cancer . Trimeris ’ second fusion inhibitor product candidate , T-1249 , has received fast track status from the FDA and is in Phase I / II clinical testing . Trimeris ' second fusion inhibitor product candidate , T-1249 , has received fast track status from the FDA and is in Phase I / II clinical testing .